by Sola Ogundipe

November 3, 2012
from Vanguardngr Website

Following a recent study conducted by scientists at the University of Pittsburgh, Pennsylvania which revealed that many infant monkeys given standard doses of childhood vaccines as part of the new research, developed autism symptoms, question marks over the ultimate safety of vaccines have come to the fore.

The groundbreaking research findings presented at the International Meeting for Autism Research (IMSAR) in London, England, have revealed that young macaque monkeys given the typical CDC-recommended vaccination schedule from the 1990s, and in appropriate doses for the monkeys’ sizes and ages, tended to develop autism symptoms.

Their unvaccinated counterparts, on the other hand, developed no such symptoms, which points to a strong connection between vaccines and autism spectrum disorders.

This development which deconstructs mainstream myth that vaccines are safe and pose no risk of autism, was brought on by after studies on the type of proper safety research on typical childhood vaccination schedules that the U.S. Centers for Disease Control and Prevention (CDC) should have conducted - but never has - for such regimens.

Included in the mix were vaccines containing Thimerosal, a toxic, mercury-based compound that has been phased out of some vaccines, but is still present in batch-size influenza vaccines and a few others.

Also administered was the controversial measles, mumps, and rubella (MMR) vaccine, which has been linked time and time again to causing autism and various other serious, and often irreversible, health problems in children.

“This research underscores the critical need for more investigation into immunizations, mercury, and the alterations seen in autistic children,” said Lyn Redwood, Director of SafeMinds, a public safety group working to expose the truth about vaccines and autism.

“SafeMinds calls for large scale, unbiased studies that look at autism medical conditions and the effects of vaccines given as a regimen.”

Adding to the sentiment, Theresa Wrangham, president of SafeMinds called out the CDC for failing to require proper safety studies of its recommended vaccination schedules.

Unlike all other drugs, which must at least undergo a basic round of safety testing prior to approval and recommendation, vaccinations and vaccine schedules in particular do not have to be proven safe or effective before hitting the market.

“The full implications of this primate study await publication of the research in a scientific journal,” said Wrangham.

 

“But we can say that it demonstrates how the CDC evaded their responsibility to investigate vaccine safety questions. Vaccine safety oversight should be removed from the CDC and given to an independent agency.”